Wednesday, January 21, 2009

Parkinson’s Disease Drug “Trerief” Obtained Manufacturing and Marketing Approval

Jan. 21, 2009-Dainippon Sumitomo Pharma Co., Ltd. announces that the Company has obtained a manufacturing and marketing approval for “TRERIEF tablet 25 mg” (zonisamide) as of January 21, 2009 from Ministry of Health, Labor and Welfare.

The details can be read here.

No comments: